Drug-induced hypertension is associated with improved survival in glioblastoma patients treated with bevacizumab: evidence from a time-to-event meta-analysis and meta-regression

Key Points

• Survival improved as drug-induced hypertension emerged in glioblastoma patients.
• The analysis identified a significant correlation with improved survival rates under bevacizumab treatment.
• Employing a time-to-event meta-analysis allowed for comprehensive data synthesis across multiple studies.
• Implications suggest hypertension could be a beneficial response to treatment; further exploration needed.